ARCHIVES

DCT Board Approves Three New BRMP RFAs For Immunologic Research, $1.5 Million A Year

This article is from The Cancer Letter archive.

Vol. 13 No. 09 | February 27, 1987

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

May 30, 2003

In Brief: Henderson Chairs Reorganized NCA Centers Subcommittee; Core Grant Guidelines On Agenda

August 22, 1980

NCI To Ask HCFA to Launch Pilot Clinical Trials Program

March 22, 1996

Unclear Whether Insurance Will Cover AACR Losses

April 25, 2003

Two Studies Suggest Positive HPV Status Can Indicate Improved Patient Outcomes

February 28, 2014

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

January 8, 1999